Adaptive Biotechnologies Corp — Director's Dealing 2019

Jul 3, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2019-07-01

Reporting Person: ZOLTNERS ANDRIS A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-01	Common Stock	C	300000	—	Acquired	300000	Direct
2019-07-01	Common Stock	C	992583	—	Acquired	1292583	Direct
2019-07-01	Common Stock	C	1895806	—	Acquired	3188389	Direct
2019-07-01	Common Stock	C	454545	—	Acquired	3642934	Direct
2019-07-01	Common Stock	C	223082	—	Acquired	3866016	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-01	Series A Preferred Stock	$	C	300000	Disposed		Common Stock (300000)	Direct
2019-07-01	Series B Preferred Stock	$	C	992583	Disposed		Common Stock (992583)	Direct
2019-07-01	Series C Preferred Stock	$	C	1895806	Disposed		Common Stock (1895806)	Direct
2019-07-01	Series E-1 Preferred Stock	$	C	454545	Disposed		Common Stock (454545)	Direct
2019-07-01	Series F Preferred Stock	$	C	223082	Disposed		Common Stock (223082)	Direct

Footnotes

F1: Reflects automatic conversion of Series A Preferred Stock into common stock on a one-for-one basis upon the closing of the initial public offering of Issuer's common stock.

F2: Reflects automatic conversion of Series B Preferred Stock into common stock on a one-for-one basis upon the closing of the initial public offering of Issuer's common stock.

F3: Reflects automatic conversion of Series C Preferred Stock into common stock on a one-for-one basis upon the closing of the initial public offering of Issuer's common stock.

F4: Reflects automatic conversion of Series E-1 Preferred Stock into common stock on a one-for-one basis upon the closing of the initial public offering of Issuer's common stock.

F5: Reflects automatic conversion of Series F Preferred Stock into common stock on a one-for-one basis upon the closing of the initial public offering of Issuer's common stock.